Caroline Austin

Caroline Austin has a diverse work experience spanning over several decades. Caroline is currently serving as a Non-Executive Director at Qureight, a clinical data analytics company based in Cambridge, UK. In this role, they collaborate with healthcare institutions, technology companies, and the pharmaceutical industry to implement new endpoints in clinical data.

Prior to their current position, Caroline held various roles at AstraZeneca, a pharmaceutical company. Caroline served as the Vice President and Head of Transactions, Business Development, where they led strategic transactions and business development efforts. Caroline also held the position of Executive Transaction Director and Head of Precision Medicine Genomics Business Development, overseeing the development of precision medicine initiatives.

Caroline's career at AstraZeneca also includes roles such as Transaction Director for Global Portfolio & Product Strategy and Business Development Director for Strategic Partnering and Business Development. Caroline began their tenure at AstraZeneca as a Business Development and Alliance Manager.

Before joining AstraZeneca, Caroline worked as a Senior Research Scientist at Astra Pharmaceuticals from 1996 to 2001. Prior to that, they were a Research Fellow at the Johns Hopkins School of Medicine in Baltimore, USA, and a Post-doctoral Research Scientist at the University College London Hospitals NHS Foundation Trust.

Caroline has a strong background in pharmaceuticals, business development, and clinical data analytics, making their a valuable asset in the healthcare industry.

Caroline Austin attended King's College London where they earned a BSc in Physiology. Caroline then pursued further education at the same institution and completed an MSc in Pharmacology. Finally, Caroline enrolled in a PhD program at UCL, focusing on Pharmacology, but no specific start or end years were provided for any of their educational experiences.